Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

By LabMedica International staff writers
Posted on 20 Sep 2023

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple bodily functions such as balancing fluids, transmitting nerve signals, and aiding in muscle contraction and relaxation. Electrolyte analyzers work on the principle of ion-selective electrodes, which can specifically identify certain ions and generate an electrical output corresponding to their concentration. Factors like technological innovations, the rising prevalence of chronic diseases, and the growing demand for point-of-care (POC) testing are driving the growth of the global market for fully automatic electrolyte analyzers. The market was valued at USD 0.44 billion in 2022, and is projected to reach USD 0.77 billion by 2032, registering a CAGR of 5.7% from 2023 to 2032.

These are the latest findings of Allied Market Research (Portland, OR, USA), a full-service market research and business-consulting firm.

Several factors are contributing to the growth of the fully automatic electrolyte analyzers market. Among them are the increasing global demand for POC testing, a growing tendency to adopt fully automatic analyzers, and rising imports of these devices in developing nations. POC testing is gaining traction because it offers quick and precise results right where the patient is, thereby further fueling market growth. However, the steep prices of these automated analyzers are limiting market growth. Despite this, an increased emphasis on preventive healthcare is likely to create new opportunities for market players in the coming years.

On the basis of product type, the integrated segment held the lion's share in 2022, accounting for close to two-thirds of total market revenue. This segment is expected to maintain its leading position and is also projected to grow at the fastest CAGR of 6%, due to increasing preference for integrated over standalone devices. These integrated systems offer quicker processing times and easier data handling because they can be connected to laboratory information systems.

Based on modality, the benchtop segment held the largest share in 2022, accounting for over two-thirds of market revenue. This segment is expected to maintain its dominant position largely due to the extensive range of benchtop models provided by major companies. The portable segment, however, is expected to grow at the fastest CAGR of 6.3% during the forecast period due to the increasing demand for POC testing, which in turn is boosting the demand for portable electrolyte analyzers.

Based on end user, diagnostic centers held the largest market share in 2022, accounting for more than two-fifths of the total revenue. These centers favor automatic analyzers as they allow for quick processing of multiple samples, thereby enabling timely reporting to healthcare professionals. Meanwhile, the hospitals segment is likely to experience the highest CAGR of 6.1% in the forecast period, as rising patient admissions are spurring the adoption of these analyzers in hospital environments.

Based on region, North America led the market in 2022, accounting for nearly two-fifths of the global market revenue and is expected to maintain its dominant position during the forecast period. The North American fully automated electrolyte analyzers market is witnessing notable growth, owing to an increase in the prevalence of chronic diseases such as diabetes and cardiovascular diseases. On the other hand, the Asia-Pacific market is expected to witness the fastest CAGR of 6.5% during the forecast period, owing to an increase in the prevalence of hypertension and rise in adoption of advanced fully automatic electrolyte analyzers in the region.

Related Links:
Allied Market Research 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.